July 15, 2005 -- Stem Cell Sciences Ltd. raised 6 million pounds sterling ($10.4 million) in an IPO on London’s Stock Exchange AIM, selling 6.2 million shares at 97p. The post money valuation will be 21 million pounds sterling ($36.5 million). The shares are expected to list on Monday. Using embryonic stem cell therapy, Stem Cell Sciences is focused on treatments for diabetes and Parkinson’s. We look at the history of the company, its alliances, and its platform...
